JMI LABS IS NOW PART OF LEARN MORE

In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans. by Yamazumi T, Pfaller MA, Messer SA, Houston A, Hollis RJ and Jones RN published in Antimicrob. Agents Chemother. 2000; 44 (10): 2883-2886

View publication